Kusajili – Clinical trials directory

Result of your search per sponsor: Pfizer Luxembourg SARL Latvia Branch

Woman and Man Max 99 years
Pfizer Luxembourg SARL Latvia Branch Update Il y a 4 ans

A randomised, placebo controlled, double blind trial of asenapine in the prevention of relapse after long term treatment of schizophrenia To determine the efficacy of asenapine compared to placebo with respect to the time to an impending relapse in schizophrenia subjects who received treatment with asenapine for 26 weeks.

Country None
organs None
Specialty None

Closed trial

More information